For Corporates

Get in touch

Become part of the ecosystem nurturing biotech innovation.

Medical, food and agricultural technologies are research fields that are essential for the development of new business models, brand strength, future viability and risk minimization with regard to the resilience of business locations.

To exploit the full scientific and economic potential, there is currently a lack of appropriate laboratory facilities and access to industry and capital. Our approach is to create an ecosystem that connects contributing founders, scientists, entrepreneurs, investors and cutting-edge thinkers. 

We bridge the gap between the startup and corporate, bringing together the best of both worlds. We build commercially and socially valuable startups that make a difference - for our society, our planet and our economy.

Mission

Building an inclusive, resilient and dynamic ecosystem for co-creation, scalable application and real impact.

We believe that real innovation is based on real science. This is why we focus on creating value along the entire lab-to-market value chain, across the scientific, technical, legal, commercial, financial, regulatory and strategic fields.

Vision

Creating an abundant future through connecting science and entrepreneurship and solving humanities most pressing challenges.

We build commercially and socially valuable startups that make a difference - for our society, our planet and our economy.

Sectors

Biotech

Cross-Sections

Cross-Section

Biotech

Biotech

Biotech

The new building blocks of biology now stretch far beyond their origin. From AI to scaling and automation, these platforms are expanding the limits of what biology can do, from the lab bench to the world.

Cross-Section

Biotech

Cross-Sections

Biotech

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Food Sciences

Food sciences happen at the intersection of biology, chemistry and other technologies that analyze and study the core elements of food. They focus on novel approaches to increase nutritional content of the food we eat, develop new sources of food and pioneer novel solutions to make our food sources healthier and safer.

Cross-Section

Biotech

Cross-Sections

Food Sciences

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Life Sciences

Life sciences is the study of living organisms and life processes. As we enter a new era of medicine, novel insights and techniques across biochemistry, biophysics, and structural biology are expanding the horizon of what we can prevent, diagnose, and treat. Engineered cells, gene therapy, smart, personalized and targeted medicine, are all among the next generation of analytics and therapeutics that will define how we will live.

Cross-Section

Biotech

Cross-Sections

Life Sciences

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Agricultural Sciences

Agricultural sciences combine novel technologies across crop science, data analytics, robotics, automation, and beyond. Faced with an ever-growing demand for agricultural output on our already strained planet, these technologies help engineer novel, more innovative, healthier, and greener means of production while they also increase crop management efficiency and offer techniques for large-scale deployment.

Cross-Section

Biotech

Cross-Sections

Agricultural Sciences

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Artificial Intelligence

Artificial Intelligence (AI) constitutes a field of technologies, such as machine learning and deep learning, that use computational analysis of large datasets of all sorts. The scale of complexity enhancement, it can develop across a wide range of scientific fields, makes AI a truly revolutionizing cross-sectional technology. By performing tasks that usually require human intelligence, such as visual, speech or pattern recognition, process optimization or other forms of decision making, and using those for simulation or predictive capacity, AI holds the power to fundamentally improve the process of scientific innovation.

Cross-Section

Biotech

Cross-Sections

Artificial Intelligence

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Cognitive Algorithms

Cognitive algorithms are a form of AI technology that can perform any form of learning and reasoning, be it in supervised or unsupervised manner. Its transformative power lies in its ability to replicate, simulate, complement, and enhance human behavior across a wide range of application fields.

Cross-Section

Biotech

Cross-Sections

Cognitive Algorithms

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Robotic Process Automation

Robotic Process Automation (RPA) is a software technology running on physical or virtual machines that mimics and automates specific processes and actions by managing software derived robots that ultimately perform the tasks. These (metaphorical) software robots are so transformative since they can not only emulate how human beings interact with software in general, but also perform high-volume and repetitive tasks with applications in a wide array of industries.

Cross-Section

Biotech

Cross-Sections

Robotic Process Automation

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Sensor Technology

Sensor technology is a key cross-section technology as it is by definition the connecting “door” between the physical and the virtual world. The deployment of sensors is key to acquiring and collecting data by transforming information of physical, chemical or biological nature and forms the basis on which computational systems and other data processing technologies can be applied.

Cross-Section

Biotech

Cross-Sections

Sensor Technology

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Bioengineering

Bioengineering is a crucial cross-section technology as it applies the tools of engineering, mathematics and physical sciences with the principles of biology, medicine and life sciences. By applying design, analysis and processes to biological systems and biomedical technologies novel fields of application emerge.

Cross-Section

Biotech

Cross-Sections

Bioengineering

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Nanotechnology

Nanotechnology is defined as the technology field dealing with structures, devices and systems that have dimensions in the order of 100 nanometres, or 100 millionth of a millimetre, or less. By designing, producing or manipulating atoms and molecules at the nanoscale, novel technological solutions and revolutionizing applications become possible across a multitude of scientific fields.

Cross-Section

Biotech

Cross-Sections

Nanotechnology

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We accelerate the development of solutions that contribute to your Sustainable Development Goals.
10+
Biotech Startups
1.000 m2
in operation
10.000 m2
under construction

Our Scope

Innovation pipeline

By establishing a formal innovation pipeline, organizations can ensure that new ideas are thoroughly evaluated and developed, reducing the risk of costly failures and increasing the likelihood of successful innovation.

We offer a structured approach to generate and implement startup ideas within your organization. It involves a series of steps and stages that allow for the exploration, development, and commercialization of abundant biotech services, or processes.

The stages of our pipeline consulting covers researching, identifying potential sectors for innovation, evaluation based on factors such as feasibility, potential profitability, and alignment with company goals, concept development, MVP testing and early cooperation to achieve a sound validation.

Startup scouting

We offer the process of identifying and evaluating potential startup companies for corporate investment, acquisition, or partnership opportunities. We deliver various services to succeed with startup company scouting, including programs that provide resources and mentorship to second and early-stage startups.

We have academic and industry experts who can help identify promising startups and provide guidance on their potential. Our market research and our early stage networks shows insights on market trends and opportunities, which focus to identify potential innovation range and young companies that are addressing those sectors.

Funding

Corporate venturing is a strategy in which established companies invest in or acquire startup companies in order to access new technologies, markets, or business models. This allows the established companies to innovate and diversify their portfolios without having to develop everything in-house.

Our funding service could be an essential component of your corporate venturing. We offer you to be part in our deep tech venture fund to invests in startup of your vertical sector. In return  and combined with our direct navigator services for startup companies you can gain access to their innovative technology, business model, and strengthen your market position.

Publication

We provide exceptional reader & leader services. We publish professional content and stories that showcases the innovation verticals beyond the the science talk. Our purpose is to match the common sense expectations.

We include testimonials and case studies from trends, therapy fields, food solutions and other achievements and provide a clear way for potential innovations, you could get in professional touch. We reach a wider audience, deliver high-quality work on time, and go above and beyond to exceed our readers' expectations.

Continuously improve your knowledge, competences and insights. Stay up to date on the latest science trends, invest in ongoing promising startup companies, and constantly gain feedback from Abundance Gate to improve your business.

“Exponential tech creates abundance, let’s take the opportunities and advantages.“
At Abundance Gate we give you the power to accelerate your technology developing your business. We provide professional services and competences to foster late seed and series stage start ups companies. Our ecosystem is a compelling place to work, a compelling place to achieve.

Thomas Holzhuber
CEO | Co- Founder
Darryl McConnel

"At Boehringer Ingelheim, we are always looking to support new technologies and creative approaches to develop more effective treatments for disease. We welcome Abundance Gate and their Lab to Market infrastructure initiative. As an innovation-driven company, we are looking forward to the enrichment for biotech startups in Vienna. As a corporate player in life science we value the dynamic atmosphere of Abundance Gate, which startup companies need to succeed."

Darryl McConnel
Senior Vice President, Research Site Head Austria bei Boehringer Ingelheim RCV GmbH & Co KG
Timur Topalgoekceli

"Biotech start-ups benefit society by solving unsolved scientific and medical problems, but more needs to be done to bring their technologies to market faster. This requires dedicated mentors, selective training, a community, network connections and access to sources of capital. This is where Abundance Gate comes in: Programmes that provide intensive mentoring, selective training, a community of startup founders and exposure to companies and investors." 

Timur Topalgoekceli
Startup Lead | Co-Founder
Thomas Holzhuber

“Exponential tech creates abundance, let's take the opportunities and advantages.” At Abundance Gate we give you the power to accelerate your technology developing your business. We provide professional services and competences to foster late seed and series stage startup companies. Our ecosystem is a compelling place to work, a compelling place to achieve.

Thomas Holzhuber
CEO & Co- Founder
Arne Materna

“Ares Genetics, an OpGen Group Company, is developing next-generation services and solutions for the genomic diagnosis and surveillance of infectious diseases and the AI-assisted prediction of pathogen response to antibiotic therapy. We chose Abundance Gate for our new home base in Vienna due to state of the art lab space and facility services that are tailored to our needs. The Abundance Gate incubator can offer the dynamic atmosphere needed to take your business idea to the next level.”

Arne Materna
CEO, Ares Genetics
Taraneh Abdelrahimsei

"Community building & stakeholder engagement is one of the most important areas in leading successful businesses. Knowledge transfer, understanding market needs, driving innovation as well as identifying risks and opportunities evolve from regular and ongoing discourse with the community.“

Taraneh Abdelrahimsei
Community Relations
Berthold Baurek-Karlic

"Venionaire is an independent Venture Capital specialist and trusted partner of many investors- from Family Offices to large corporates. We are entrepreneurial partners and provide startups a global platform and network to scale. Abundance Gate is a highly valued partner of ours in acceleration and business development. Abundance Gate provides expertise and passion to navigate start-ups through early technology challenges, first product market fit and achieve commercial readiness for scale. "

Berthold Baurek-Karlic
CEO of Venionaire Capital
Irene Fialka

"INiTS is the Vienna‘s high-tech incubator. We have supported researchers to launch and grow innovative research/technology-based startups since 2002. Abundance Gate is a great enrichment to the LifeSciences scene in Austria, offering startups urgently needed lab space and network to take them to the next level during and after their time with INiTS. We really appreciate this private initiative, which helps to keep companies with their technologies and employees in Vienna and contribute to the competitiveness of our LifeSciences industry."

Irene Fialka
CEO Managing Director Health Hub Vienna
Niki Futter

"As a series and experienced business angel I value the approach how Abundance Gate enters the market of the biotech and bioengineering startup ecosystem. The professional acceleration program to guide and lead science technology to sound business is an outstanding success driver. Abundance Gate opens a great pipeline to invest in the most promising biotech startups."

Niki Futter
Investor, Series Business Angel, President AAIA

Interested in becoming Part of our Abundance ecosystem?

Find out more about our innovation services
Discover more

Values

Living values is essential for creating a successful and ethical business.
More news

Willing to accelerate? Get your boost!

Contact us with any questions or inquiries you may have! We’d love to chat.

Have someone specific in mind?

Stay connected!

Looking to learn more about acceleration, collaboration or investment opportunities within the Abundance Gate ecosystem?

Sign up for our newsletter to stay in touch!